Cargando…
Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder
IMPORTANCE: Buprenorphine is an approved medication for opioid use disorder (MOUD); however, prescribing buprenorphine is limited by a requirement to obtain a waiver to prescribe it (hereinafter, “DATA [Drug Abuse Treatment Act]–waiver”) and a lack of knowledge of the best practices among clinicians...
Autores principales: | Solmeyer, Anna R., Berger, Aaron T., Barton, Sean L., Nguyen, Benjamin, Bart, Gavin B., Grahan, Brian, Bell, Heather J., DeVine, Kurt M., Merrick, Weston |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675001/ https://www.ncbi.nlm.nih.gov/pubmed/36399352 http://dx.doi.org/10.1001/jamahealthforum.2022.4149 |
Ejemplares similares
-
Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023) -
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022) -
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022) -
Army and Navy ECHO Pain Telementoring Improves Clinician Opioid
Prescribing for Military Patients: an Observational Cohort Study
por: Katzman, Joanna G., et al.
Publicado: (2018) -
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)